Daiwa Securities Group
TIL icon

Daiwa Securities Group’s Instil Bio TIL Stock Holding History

Daiwa Securities Group’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18
Closed – – 1352
2023
Q4 		$0 Sell
18
-1
-5% -$7 ﹤0.01% 1392
2023
Q3 		$0 Hold
19
– – ﹤0.01% 1337
2023
Q2 		$0 Hold
19
– – ﹤0.01% 1349
2023
Q1 		$0 Hold
19
– – ﹤0.01% 1320
2022
Q4 		$0 Hold
19
– – ﹤0.01% 1386
2022
Q3 		$2K Hold
19
– – ﹤0.01% 1250
2022
Q2 		$2K Hold
19
– – ﹤0.01% 1257
2022
Q1 		$4K Hold
19
– – ﹤0.01% 1200
2021
Q4 		$6K Buy
+19
New +$7.33K ﹤0.01% 1185

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Daiwa Securities Group's TIL Position: Q1 2024 in Review

Daiwa Securities Group sold out of Instil Bio (TIL) in Q1 2024, closing a stake of 18 shares.

Daiwa Securities Group first reported a position in TIL in Q4 2021 and held it in 9 quarters. The position peaked at $6K in Q4 2021. 31 funds tracked by Wall St. Rank hold TIL as of Q1 2024.

  • Daiwa Securities Group reported no remaining Instil Bio position as of Q1 2024 after selling out during the quarter.
  • Daiwa Securities Group sold 18 Instil Bio shares in Q1 2024.
  • Daiwa Securities Group first reported a position in Instil Bio in Q4 2021 and held it in 9 quarters.
  • Daiwa Securities Group's Instil Bio position peaked at $6K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Instil Bio as of Q1 2024.

Based on Daiwa Securities Group's 13F filing for Q1 2024, filed 2 May 2024.